GB9901254D0 - Vaccines - Google Patents

Vaccines

Info

Publication number: GB9901254D0
Authority: GB; United Kingdom
Prior art keywords: vaccines
Prior art date: 1999-01-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9901254.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GlaxoSmithKline Biologicals SA

Original Assignee

SmithKline Beecham Biologicals SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-20

Filing date

1999-01-20

Publication date

1999-03-10

1999-01-20 Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA

1999-01-20 Priority to GBGB9901254.4A priority Critical patent/GB9901254D0/en

1999-03-10 Publication of GB9901254D0 publication Critical patent/GB9901254D0/en

2000-01-17 Priority to PCT/EP2000/000352 priority patent/WO2000043527A1/en

2000-01-17 Priority to AU22926/00A priority patent/AU2292600A/en

2000-01-18 Priority to ARP000100224A priority patent/AR027484A1/en

2000-01-20 Priority to CO00002923A priority patent/CO5241364A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

GBGB9901254.4A 1999-01-20 1999-01-20 Vaccines Ceased GB9901254D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GBGB9901254.4A GB9901254D0 (en)	1999-01-20	1999-01-20	Vaccines
PCT/EP2000/000352 WO2000043527A1 (en)	1999-01-20	2000-01-17	Varicella-zoster virus vaccines
AU22926/00A AU2292600A (en)	1999-01-20	2000-01-17	Varicella-zoster virus vaccines
ARP000100224A AR027484A1 (en)	1999-01-20	2000-01-18	USEFUL FUSION PROTEIN IN THE TREATMENT OR PREVENTION OF ZOSTER HERPES AND IN THE PREVENTION OR TREATMENT OF VARICEL, DNA AND RNA INFECTIONS QUECODIFY SUCH PROTEIN; EXPRESSION VECTORS AND RECOMBINANT MICROORGANISMS THAT INCLUDE SUCH DNA OR RNA; VACCINE COMPOSITIONS THAT INCLUDE DICH
CO00002923A CO5241364A1 (en)	1999-01-20	2000-01-20	VACCINES LA ZOSTER

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9901254.4A GB9901254D0 (en)	1999-01-20	1999-01-20	Vaccines

Publications (1)

Publication Number	Publication Date
GB9901254D0 true GB9901254D0 (en)	1999-03-10

Family

ID=10846213

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9901254.4A Ceased GB9901254D0 (en)	1999-01-20	1999-01-20	Vaccines

Country Status (5)

Country	Link
AR (1)	AR027484A1 (en)
AU (1)	AU2292600A (en)
CO (1)	CO5241364A1 (en)
GB (1)	GB9901254D0 (en)
WO (1)	WO2000043527A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0504436D0 (en) *	2005-03-03	2005-04-06	Glaxosmithkline Biolog Sa	Vaccine
AU2012213948B2 (en) *	2005-03-03	2016-01-21	Glaxosmithkline Biologicals S.A.	Vaccine
AU2008275895A1 (en) *	2007-07-19	2009-01-22	Novavax, Inc.	Varicella Zoster Virus-virus like particles (VLPS) and antigens
EA033467B1 (en) *	2011-01-31	2019-10-31	Univ Pennsylvania	Nucleic acid molecule for inducing an immune response against herpes virus and use thereof
KR101723605B1 (en) *	2014-10-21	2017-04-07	진원생명과학 주식회사	Dna vaccine composition for preventing and treating herpes zoster and method of activating t-cell to vzv antizen by using the same
WO2018097642A1 (en) *	2016-11-25	2018-05-31	재단법인 목암생명과학연구소	Varicella zoster virus vaccine
US10874734B2 (en)	2016-11-25	2020-12-29	Mogam Institute For Biomedical Research	Varicella zoster virus vaccine
CN112142828B (en) *	2019-06-28	2022-02-01	怡道生物科技(苏州)有限公司	gE gene and vector for expressing the gene
EP4074336A4 (en)	2019-12-13	2024-09-04	Grand Theravac Life Science (Nanjing) Co., Ltd.	PHARMACEUTICAL COMPOSITION AND USE THEREOF
CN115819616B (en) *	2021-07-28	2025-04-11	江苏瑞科生物技术股份有限公司	A gene recombinant VZV fusion protein and its preparation method and application
IL312799A (en)	2021-11-24	2024-07-01	Flagship Pioneering Innovations Vi Llc	Varicella-zoster virus immunogen compositions and their uses
CN114891830B (en) *	2022-04-02	2024-03-01	武汉博沃生物科技有限公司	Recombinant expression vector based on varicella-zoster virus, recombinant virus and application thereof
EP4653469A1 (en) *	2023-01-19	2025-11-26	Xiamen University	Fusion protein of ge and gi of varicella-zoster virus and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CY1933A (en) *	1989-06-27	1990-06-22	Smithkline Biolog	Novel compounds
GB9226768D0 (en) *	1992-12-23	1993-02-17	Smithkline Beecham Biolog	Vaccines
GB9413751D0 (en) *	1994-07-07	1994-08-24	British Bio Technology	Immunodominant peptides
JP2002504080A (en) *	1996-02-09	2002-02-05	スミスクラインビーチャムバイオロジカルズソシエテアノニム	Vaccine against varicella-shingles virus gene 63 product

1999
- 1999-01-20 GB GBGB9901254.4A patent/GB9901254D0/en not_active Ceased
2000
- 2000-01-17 WO PCT/EP2000/000352 patent/WO2000043527A1/en not_active Ceased
- 2000-01-17 AU AU22926/00A patent/AU2292600A/en not_active Abandoned
- 2000-01-18 AR ARP000100224A patent/AR027484A1/en unknown
- 2000-01-20 CO CO00002923A patent/CO5241364A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2000043527A1 (en)	2000-07-27
AR027484A1 (en)	2003-04-02
CO5241364A1 (en)	2003-01-31
AU2292600A (en)	2000-08-07

Publication	Publication Date	Title
HUP0202885A3 (en)	2004-07-28	Vaccines
IL145044A0 (en)	2002-06-30	Vaccine
HUS1300072I1 (en)	2019-11-28	Vaccine
AU4433702A (en)	2002-04-29	Vaccines
PL351486A1 (en)	2003-04-22	Prrsv vaccines
GB9901254D0 (en)	1999-03-10	Vaccines
GB9915204D0 (en)	1999-09-01	Vaccine
GB9822714D0 (en)	1998-12-09	Vaccines
GB0027072D0 (en)	2000-12-20	Vaccine
GB9913327D0 (en)	1999-08-11	Vaccine
GB9906437D0 (en)	1999-05-12	Vaccine
GB9930591D0 (en)	2000-02-16	Component for vaccine
MXPA01010701A (en)	2003-08-20	Vaccine.
GB9930585D0 (en)	2000-02-16	Component for vaccine
GB9909072D0 (en)	1999-06-16	Vaccine
GB9922700D0 (en)	1999-11-24	Vaccine
GB0004533D0 (en)	2000-04-19	Vaccines
GB9904048D0 (en)	1999-04-14	Vaccines
GB9904280D0 (en)	1999-04-21	Vaccines
GB9909466D0 (en)	1999-06-23	Vaccines
GB9915205D0 (en)	1999-09-01	Vaccine
GB9918647D0 (en)	1999-10-13	Vaccine
GB9922701D0 (en)	1999-11-24	Vaccine
GB9916677D0 (en)	1999-09-15	Vaccine
GB9922703D0 (en)	1999-11-24	Vaccine

Legal Events

Date	Code	Title	Description
2000-04-12	AT	Applications terminated before publication under section 16(1)